The HER2-OE subtype shows a high immune infiltration (10, 11), mostly composed by tumor infiltrating lymphocytes (TILs) and tumor-associated macrophages (TAMs) (12–18), which have been clinically associated with better (19, 20) and worse (21–23) prognosis, respectively. Here, ERBB2 is linked to neoplasm.